Biological Products, (No Diagnostic Substances) Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Biological Products, (No Diagnostic Substances)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

D
2018-07-13
MNTAMomenta Pharmaceuticals IncKwon YoungSVP, Corporate DevelopmentS - Sale+OE$27.39-49,500114,624-30%-$1,355,985
M
2018-07-13
ACORAcorda Therapeutics IncScopia Capital Management LP10%S - Sale$30.04-33,2997,336,5310%-$1,000,331
D
2018-07-16
SGMOSangamo Therapeutics, IncYi KathySVP, CFOS - Sale+OE$14.77-5,0007,250-41%-$73,860
2018-07-16
AMGNAmgen IncHarper Sean EEVP, Research, DevelopmentS - Sale$195.71-1,52556,082-3%-$298,458
D
2018-07-12
MNTAMomenta Pharmaceuticals IncKwon YoungSVP, Corporate DevelopmentS - Sale+OE$25.44-46,499125,624-27%-$1,183,025
D
2018-07-09
SGENSeattle Genetics Inc /waSiegall Clay BPres, CEOS - Sale+OE$69.07-18,832687,146-3%-$1,300,770
D
2018-07-09
MNTAMomenta Pharmaceuticals IncStoner ElizabethDirS - Sale+OE$23.00-4,46227,791-14%-$102,626
2018-07-09
HSKAHeska CorpNapolitano Jason ACOO, Chief Strategist, Sec.S - Sale$110.00-1,20029,474-4%-$132,000
2018-07-09
BLUEBluebird Bio, Inc.Cole JasonGCS - Sale$170.25-5,12617,172-23%-$872,715
M
2018-07-09
ATRAAtara Biotherapeutics, Inc.Ciechanover Isaac E.CEOS - Sale$40.00-58,400910,291-6%-$2,335,739
2018-05-18
HSKAHeska CorpEyl Steven M.EVP, Global Sales, MarketingS - Sale$103.00-5829,900-6%-$59,946
DM
2018-07-09
CHRSCoherus Biosciences, Inc.Finck Barbara KChief Medical OfficerS - Sale+OE$15.01-1,76037,043-5%-$26,415
M
2018-07-06
ACORAcorda Therapeutics IncScopia Capital Management LP10%S - Sale$30.61-200,3547,369,830-3%-$6,132,794
D
2018-07-06
SGMOSangamo Therapeutics, IncConner Edward R.SVP, Chief Medical OfficerS - Sale+OE$15.79-5,00010,125-33%-$78,975
D
2018-07-02
GILDGilead Sciences IncMartin John CDirS - Sale+OE$70.81-50,0003,017,762-2%-$3,540,282
D
2018-07-02
BOLDAudentes Therapeutics, Inc.Prasad SuyashSVP, Chief Med OfficerS - Sale+OE$38.41-10,0005,011-67%-$384,067
DM
2018-07-02
BOLDAudentes Therapeutics, Inc.Patterson Matthew RCEOS - Sale+OE$39.55-71,048171,814-29%-$2,809,837
DM
2018-07-03
CRSPCrispr Therapeutics AGCagnoni Pablo JDirS - Sale+OE$62.00-7,5000-100%-$465,000
M
2018-07-02
ACORAcorda Therapeutics IncScopia Capital Management LP10%S - Sale$30.07-66,3827,570,184-1%-$1,996,300
D
2018-07-02
TBIOTranslate Bio, Inc.Gallagher Brian M. Jr.DirP - Purchase$13.00+269,2303,697,912+8%+$3,499,990
2018-07-02
AERIAerie Pharmaceuticals IncKopczynski Casey C.Chief Scientific OfficerS - Sale$66.37-11,000169,517-6%-$730,064
2018-07-02
EDITEditas Medicine, Inc.Bosley KatrinePres, CEOS - Sale$36.29-8,3331,285,299-1%-$302,441
D
2018-07-02
TBIOTranslate Bio, Inc.Mrl Ventures Fund LLC10%P - Purchase$13.00+25,0001,873,503+1%+$325,000
2018-07-02
ACORAcorda Therapeutics IncBlank BurkhardChief Medical OfficerS - Sale$29.61-5,00028,150-15%-$148,050
D
2018-07-02
BLUEBluebird Bio, Inc.Davidson DavidChief Medical OfficerS - Sale+OE$153.96-10,00024,905-29%-$1,539,604
D
2018-06-29
XLRNAcceleron Pharma IncMcLaughlin Kevin FSVP, CFO, TreasurerS - Sale+OE$48.00-25,00043,939-36%-$1,200,000
D
2018-06-29
NTGNNeon Therapeutics, Inc.Access Industries Holdings LLC10%P - Purchase$16.00+315,0003,097,913+11%+$5,040,000
2018-06-28
VICLVical IncArmistice Capital, LLC10%P - Purchase$1.21+1,276,5918,721,000+17%+$1,538,981
2018-06-28
ACORAcorda Therapeutics IncSabella Lauren MChief Commercial OfficerS - Sale$27.84-5,8595,306-52%-$163,140
M
2018-06-27
HALOHalozyme Therapeutics IncKirk Randal J10%S - Sale$17.04-304,32117,288,450-2%-$5,186,692
2018-06-25
ONSOncobiologics, Inc.Bahrt KennethChief Medical OfficerS - Sale$0.85-7,70047,120-14%-$6,507
M
2018-06-26
ATRAAtara Biotherapeutics, Inc.Ciechanover Isaac E.CEOS - Sale$39.60-6,400968,691-1%-$253,425
D
2018-06-25
BOLDAudentes Therapeutics, Inc.Newman MarySVP, Regulatory AffairsS - Sale+OE$40.79-8,5450-100%-$348,581
2018-06-25
BOLDAudentes Therapeutics, Inc.Lange Louis GDirS - Sale$40.59-33,000471,591-7%-$1,339,498
M
2018-06-25
VICLVical IncArmistice Capital, LLC10%P - Purchase$1.24+51,8056,167,818+1%+$64,136
D
2018-06-25
ASTAsterias Biotherapeutics, Inc.Mulroy Michael H.Pres, CEOP - Purchase$1.63+3,06791,513+3%+$4,999
2018-06-22
MNTAMomenta Pharmaceuticals IncGilman Steven CDirS - Sale$21.50-2,2943,440-40%-$49,321
2018-06-21
ACORAcorda Therapeutics IncScopia Capital Management LP10%S - Sale$30.53-60,2957,636,566-1%-$1,840,650
2018-06-21
MNTAMomenta Pharmaceuticals IncArroyo SantiagoSVP, Chief Medical OfficerS - Sale$22.20-2,66533,335-7%-$59,163
D
2018-06-20
BOLDAudentes Therapeutics, Inc.Nagler DavidSVP, HR, Corp. AffairsS - Sale+OE$45.29-5,0000-100%-$226,461
M
2018-06-20
VICLVical IncArmistice Capital, LLC10%P - Purchase$1.26+18,3626,064,2080%+$23,061
D
2018-06-21
MNTAMomenta Pharmaceuticals IncStoner ElizabethDirS - Sale+OE$22.20-2,28826,253-8%-$50,794
2018-06-20
RGNXRegenxbio Inc.Mills Kenneth T.Pres, CEOS - Sale$66.20-5,000203,530-2%-$331,018
D
2018-06-20
NBIXNeurocrine Biosciences IncGrigoriadis Dimitri E.CHIEF RESEARCH OFFICERS - Sale+OE$105.00-23,00082,942-22%-$2,415,000
2018-06-20
TROVTrovagene, Inc.Markin Rodney SDirP - Purchase$0.85+41,20063,810+182%+$35,020
M
2018-06-18
ACORAcorda Therapeutics IncScopia Capital Management LP10%S - Sale$30.68-393,1847,696,861-5%-$12,062,607
DM
2018-06-18
EDITEditas Medicine, Inc.Myer VickeshCTOS - Sale+OE$38.26-14,0000-100%-$535,572
2018-06-18
BLUEBluebird Bio, Inc.Gregory Philip DChief Scientific OfficerS - Sale$178.41-3,90125,371-13%-$695,978
D
2018-06-18
RGNXRegenxbio Inc.Christmas Patrick J.SVP, GCS - Sale+OE$56.78-5,00017,669-22%-$283,886
D
2018-06-18
CHRSCoherus Biosciences, Inc.Finck Barbara KChief Medical OfficerS - Sale+OE$15.00-1,76037,043-5%-$26,400
D
2018-06-18
VCELVericel CorpWotton Paul KDirS - Sale+OE$12.06-30,0000-100%-$361,800
2018-06-18
ATRAAtara Biotherapeutics, Inc.Gallagher Carol GiltnerDirS - Sale$44.78-2,500110,192-2%-$111,944
D
2018-06-15
ACORAcorda Therapeutics IncSmith Ian FDirS - Sale+OE$31.42-25,0000-100%-$785,568
2018-06-15
RGNXRegenxbio Inc.Vasista VittalCFOS - Sale$56.61-7,500137,283-5%-$424,540
2018-06-15
JNCEJounce Therapeutics, Inc.Cole Hugh MChief Business OfficerP - Purchase$7.84+1,9001,900New+$14,896
M
2018-06-14
VICLVical IncArmistice Capital, LLC10%P - Purchase$1.17+42,8456,027,484+1%+$50,052
2018-06-14
BLUEBluebird Bio, Inc.Vachon MarkDirS - Sale$189.99-1,0000-100%-$189,992
M
2018-06-13
ACORAcorda Therapeutics IncScopia Capital Management LP10%S - Sale$31.62-216,9108,090,045-3%-$6,857,656
D
2018-06-15
SGMOSangamo Therapeutics, IncYi KathySVP, CFOS - Sale+OE$15.67-5,0007,250-41%-$78,365
2018-06-13
NBIXNeurocrine Biosciences IncLyons Gary ADirS - Sale$99.24-15,000260,697-5%-$1,488,549
DM
2018-06-13
NBIXNeurocrine Biosciences IncGrigoriadis Dimitri E.CHIEF RESEARCH OFFICERS - Sale+OE$99.48-86,96382,942-51%-$8,650,738
D
2018-06-13
EDITEditas Medicine, Inc.Albright CharlesChief Scientific OfficerS - Sale+OE$35.98-10,0000-100%-$359,800
2018-06-15
CLXTCalyxt, Inc.Cellectis S.A.10%P - Purchase$19.49+63,17522,713,1750%+$1,231,281
D
2018-06-12
SGENSeattle Genetics Inc /waCline Darren SEVP, CommercialS - Sale+OE$69.00-12,05469,863-15%-$831,688
A
2018-06-08
TROVTrovagene, Inc.Tennant StanleyDirP - Purchase$0.80+10,00028,839+53%+$8,000
A
2018-06-08
TROVTrovagene, Inc.Brancaccio John PDirP - Purchase$0.80+10,00013,598+278%+$8,000
M
2018-06-11
VICLVical IncArmistice Capital, LLC10%P - Purchase$1.16+670,8975,941,794+13%+$779,329
D
2018-06-11
AERIAerie Pharmaceuticals IncAnido Vicente JrCEOS - Sale+OE$62.01-50,000126,320-28%-$3,100,295
2018-06-11
NBIXNeurocrine Biosciences IncSherwin Stephen ADirS - Sale$98.44-10,00047,548-17%-$984,420
2018-06-12
ACORAcorda Therapeutics IncLawrence DavidChief, Bus. Ops, PAOS - Sale$31.74-3,4314,693-42%-$108,904
M
2018-06-08
ACORAcorda Therapeutics IncScopia Capital Management LP10%S - Sale$31.27-167,7738,306,955-2%-$5,246,462
D
2018-06-08
SGENSeattle Genetics Inc /waSiegall Clay BPres, CEOS - Sale+OE$65.12-18,832687,146-3%-$1,226,341
2018-06-12
AMGNAmgen IncHarper Sean EEVP, Research, DevelopmentS - Sale$184.27-1,52557,510-3%-$281,012
M
2018-06-08
MGTXMeiragtx Holdings PlcPerceptive Advisors LLCDir, 10%P - Purchase$15.01+1,383,3334,703,398+42%+$20,760,995
D
2018-06-08
ACORAcorda Therapeutics IncSabella Lauren MChief Commercial OfficerS - Sale+OE$35.00-24,37511,165-69%-$853,125
2018-06-11
BCDABiocardia, Inc.Altman PeterPres, CEOP - Purchase$1.45+3,000703,8420%+$4,350
2018-06-08
HSKAHeska CorpWisnewski NancyEVP, Diag. Ops, Prod. Dev.S - Sale$106.50-75034,873-2%-$79,875
2018-06-08
HSKAHeska CorpGordon G IrwinDirS - Sale$106.18-3,40016,606-17%-$361,025
2018-06-07
HSKAHeska CorpGordon G IrwinDirS - Sale$103.86-3,40020,006-15%-$353,129
DM
2018-06-07
ACORAcorda Therapeutics IncLawrence DavidChief, Bus. Ops, PAOS - Sale+OE$28.19-25,0008,124-75%-$704,783
2018-06-08
ADMAAdma Biologics, Inc.Grossman Jerrold BDirP - Purchase$4.78+52,302167,857+45%+$250,004
2018-06-08
ADMAAdma Biologics, Inc.Grossman Adam SPres, CEOP - Purchase$4.78+73,2221,409,785+5%+$350,001
2018-06-08
ADMAAdma Biologics, Inc.Guiheen Lawrence P.DirP - Purchase$4.78+20,00026,000+333%+$95,600
2018-06-08
ADMAAdma Biologics, Inc.Lenz BrianVP, CFOP - Purchase$4.78+5,00020,000+33%+$23,900
2018-06-08
ADMAAdma Biologics, Inc.Richman Eric IDirP - Purchase$4.78+5,23036,530+17%+$24,999
2018-06-08
TROVTrovagene, Inc.Brancaccio John PDirP - Purchase$0.80+10,00053,167+23%+$8,000
2018-06-08
TROVTrovagene, Inc.Tennant StanleyDirP - Purchase$0.80+10,000236,061+4%+$8,000
2018-06-06
AERIAerie Pharmaceuticals IncKopczynski Casey C.Chief Scientific OfficerS - Sale$58.75-11,000180,517-6%-$646,237
DM
2018-06-06
AERIAerie Pharmaceuticals IncAnido Vicente JrCEOS - Sale+OE$62.28-150,000126,320-54%-$9,342,381
M
2018-06-04
VXRTVaxart, Inc.Finney Michael J.DirP - Purchase$3.40+5,000233,978+2%+$17,021
2018-06-06
HSKAHeska CorpGordon G IrwinDirS - Sale$105.77-3,40023,406-13%-$359,613
D
2018-06-07
TECHBio-Techne CorpKummeth Charles R.CEOS - Sale+OE$160.00-8,00076,472-9%-$1,280,000
M
2018-06-05
NKNantkwest, Inc.Gorlin SteveDirS - Sale$3.73-79,456568,000-12%-$296,225
D
2018-06-05
CRSPCrispr Therapeutics AGEmster Kurt VonDirS - Sale+OE$12.51-920381,7330%-$11,509
2018-06-06
RGENRepligen CorpRyan Thomas F JrDirS - Sale$44.31-1,9327,354-21%-$85,606
2018-06-05
MNTAMomenta Pharmaceuticals IncKwon YoungSVP, Corporate DevelopmentS - Sale$24.90-1137,6230%-$25
M
2018-06-05
KRYSKrystal Biotech, Inc.Krishnan SumaCOO, 10%P - Purchase$11.02+25,0004,100,086+1%+$275,609
D
2018-06-06
SGMOSangamo Therapeutics, IncConner Edward R.SVP, Chief Medical OfficerS - Sale+OE$16.67-5,00010,125-33%-$83,350
2018-06-05
HSKAHeska CorpGordon G IrwinDirS - Sale$105.66-3,40026,806-11%-$359,240
M
2018-06-05
ATRAAtara Biotherapeutics, Inc.Ciechanover Isaac E.CEOS - Sale$48.56-8,800975,091-1%-$427,288

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top